Reviva Pharmaceuticals Holdings Inc. (RVPH)
Official siteHEALTHCARE • BIOTECHNOLOGY • PINK
Market Cap: $4.63M
Last updated: Nov 16, 2026 at 4:00 PM ET
Reviva Pharmaceuticals Holdings Inc. (RVPH) Statistics
Reviva Pharmaceuticals Holdings (RVPH) has a market cap of $4.63M. It holds $17.41M more cash than debt, 376.00% of its market cap.
Total Valuation
| Market Cap | $4.63M |
|---|---|
| Close (Nov 16, 2026) | $0.35 |
Key Dates
| Last Earnings Date | Nov 12, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is down 96.76% over 52 weeks and trades 23.91% below its 50-day average.
| Beta (1Y) | 1.41 |
|---|---|
| 52-Week Change | -96.76% |
| 1-Month Change | -25.53% |
| 3-Month Change | -23.83% |
| 6-Month Change | -14.54% |
| 5-Year Change | -99.50% |
| Total Return (1Y) | -96.76% |
| Total Return (3Y CAGR) | -83.67% |
| Total Return (5Y CAGR) | -65.12% |
| Max Drawdown (1Y) | -97.72% |
| Max Drawdown (3Y) | -99.70% |
| Sharpe Ratio (1Y) | -1.95 |
| Correlation with SPY (1Y) | 0.11 |
| 50-Day Average | $0.46 |
| 200-Day Average | $1.18 |
| 52-Week Range | $0.26 to $15.40 |
| RSI (14 Days) | 42.0 |
| Average Volume (20 Days) | 34.54K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.39x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 3.39x |
|---|---|
| Quick Ratio | 3.39x |
| Debt / Equity | 0.00x |
| Interest Coverage | -2302.37x |
Returns and Efficiency
Return on invested capital is -90.21% and return on equity is -86.48% over the last 12 months.
| Return on Equity (ROE) | -86.48% |
|---|---|
| Return on Assets (ROA) | -60.95% |
| Return on Invested Capital (ROIC) | -90.21% |
Scores
RVPH has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$11.88M |
| Pretax Income | -$11.30M |
| Net Income | -$11.31M |
| Reported EPS (TTM) | -$6.01 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 70.47% of the $18.56M in total assets.
| Cash and Equivalents | $17.46M |
|---|---|
| Total Debt | $44.39K |
| Net Cash | $17.41M |
| Net Cash Per Share | $1.32 |
| Working Capital | $13.08M |
| Shareholder Equity | $13.08M |
| Book Value Per Share | $0.99 |
| Total Assets | $18.56M |
| Total Liabilities | $5.48M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$13.90M |
|---|---|
| FCF Per Share | -$1.06 |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
RVPH does not pay a dividend.
| Buyback Yield | -246.20% |
|---|---|
| Shareholder Yield | -246.20% |
Stock Splits
The last split was a 1-for-20 reverse split on Mar 9, 2026.
| Last Split Date | Mar 9, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:20 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About RVPH
What is RVPH's market cap?
Reviva Pharmaceuticals Holdings has a market cap of $4.63M.
How many shares of RVPH are outstanding?
Reviva Pharmaceuticals Holdings has 13.21M shares outstanding.
Does RVPH pay a dividend?
No. Reviva Pharmaceuticals Holdings does not pay a dividend.
How much debt does RVPH have?
Reviva Pharmaceuticals Holdings has $44.39K of total debt and $17.46M of cash and equivalents, a net cash position of $17.41M.
RVPH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors